Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 28:10:1631.
doi: 10.3389/fphar.2019.01631. eCollection 2019.

Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers

Affiliations

Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers

Yiwei Wang et al. Front Pharmacol. .

Abstract

Capsule networks (CapsNets), a new class of deep neural network architectures proposed recently by Hinton et al., have shown a great performance in many fields, particularly in image recognition and natural language processing. However, CapsNets have not yet been applied to drug discovery-related studies. As the first attempt, we in this investigation adopted CapsNets to develop classification models of hERG blockers/nonblockers; drugs with hERG blockade activity are thought to have a potential risk of cardiotoxicity. Two capsule network architectures were established: convolution-capsule network (Conv-CapsNet) and restricted Boltzmann machine-capsule networks (RBM-CapsNet), in which convolution and a restricted Boltzmann machine (RBM) were used as feature extractors, respectively. Two prediction models of hERG blockers/nonblockers were then developed by Conv-CapsNet and RBM-CapsNet with the Doddareddy's training set composed of 2,389 compounds. The established models showed excellent performance in an independent test set comprising 255 compounds, with prediction accuracies of 91.8 and 92.2% for Conv-CapsNet and RBM-CapsNet models, respectively. Various comparisons were also made between our models and those developed by other machine learning methods including deep belief network (DBN), convolutional neural network (CNN), multilayer perceptron (MLP), support vector machine (SVM), k-nearest neighbors (kNN), logistic regression (LR), and LightGBM, and with different training sets. All the results showed that the models by Conv-CapsNet and RBM-CapsNet are among the best classification models. Overall, the excellent performance of capsule networks achieved in this investigation highlights their potential in drug discovery-related studies.

Keywords: Capsule network; classification model; convolution-capsule network; deep learning; hERG; restricted Boltzmann machine-capsule networks.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Architecture of convolution-capsule networks (Conv-CapsNet). The input is one-dimensional vector containing 179 components. The convolution layer has 32 filters of size 1×3. The hidden feature layer and PrimaryCaps layer consist of 128 and 64 nodes, respectively. The weight matrix between PrimaryCaps layer and DigitCaps layer is 8×8×2×2, and two dynamic routing iterations were adopted.
Figure 2
Figure 2
Architecture of restricted Boltzmann machine-capsule networks (RBM-CapsNet). The input is one-dimensional vector containing 179 components. The hidden feature layer and PrimaryCaps layer consist of 256 and 128 nodes, respectively. The weight matrix between PrimaryCaps layer and DigitCaps layer is 8×8×2×2, and two dynamic routing iterations were adopted.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curves for Doddareddy's test set by (A) convolution-capsule networks (Conv-CapsNet) and (B) restricted Boltzmann machine-capsule networks (RBM-CapsNet), respectively.

Comment in

References

    1. Afshar P., Mohammadi A., Plataniotis K. N. (2018). “Brain tumor type classification via capsule networks,” in 2018 25th IEEE International Conference on Image Processing (ICIP) (Athens: IEEE; ), 3129–3133. 10.1109/icip.2018.8451379 - DOI
    1. Aliper A., Plis S., Artemov A., Ulloa A., Mamoshina P., Zhavoronkov A. (2016). Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Mol. Pharm. 13, 2524–2530. 10.1021/acs.molpharmaceut.6b00248 - DOI - PMC - PubMed
    1. Aronov A. (2005). Predictive in silico modeling for hERG channel blockers. Drug Discov. Today 10, 149–155. 10.1016/s1359-6446(04)03278-7 - DOI - PubMed
    1. Aronov A. M. (2006). Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers. J. Chem. Inf. Model. 49, 6917–6921. 10.1021/jm060500o - DOI - PubMed
    1. Bengio Y. (2009). Learning deep architectures for AI. Found. Trends Mach. Learn. 2, 1–127. 10.1561/2200000006 - DOI